Hong Kong (HSI) Life Sciences Industry Analysis

UpdatedMar 05, 2026

DataAggregated Company Financials

Companies12

7D-13.3%
3M-4.4%
1Y44.8%
YTD2.0%

Over the last 7 days, the Life Sciences industry has dropped 9.9%, driven by declines from every company within the industry. In the past year, the industry has gained 55%. Looking forward, earnings are forecast to grow by 32% annually.

Industry Valuation and Performance

Has the Hong Kong Life Sciences Industry valuation changed over the past few years?

Date	Market Cap	Revenue	Earnings	PE	Absolute PE	PS
Thu, 05 Mar 2026	HK$327.7b	HK$43.5b	HK$6.1b	38.8x	53.8x	7.5x
Sat, 31 Jan 2026	HK$366.8b	HK$43.2b	HK$6.0b	42.7x	60.8x	8.5x
Mon, 29 Dec 2025	HK$300.4b	HK$42.3b	HK$6.3b	44.4x	47.7x	7.1x
Wed, 26 Nov 2025	HK$308.4b	HK$42.0b	HK$6.2b	45.5x	49.4x	7.3x
Fri, 24 Oct 2025	HK$327.4b	HK$41.8b	HK$6.2b	46.2x	52.8x	7.8x
Sun, 21 Sep 2025	HK$342.4b	HK$41.9b	HK$6.2b	47.8x	55.1x	8.2x
Tue, 19 Aug 2025	HK$297.4b	HK$38.9b	HK$3.3b	65.5x	90.4x	7.6x
Thu, 17 Jul 2025	HK$243.9b	HK$37.2b	HK$2.7b	50.2x	89x	6.6x
Sat, 14 Jun 2025	HK$236.4b	HK$36.2b	HK$2.6b	31.1x	90.7x	6.5x
Mon, 12 May 2025	HK$188.8b	HK$35.7b	HK$2.6b	26x	73.7x	5.3x
Wed, 09 Apr 2025	HK$153.3b	HK$35.2b	HK$2.5b	23.5x	60.9x	4.3x
Fri, 07 Mar 2025	HK$197.5b	HK$35.9b	-HK$1,056,911,923.05	47x	-186.8x	5.5x
Sun, 02 Feb 2025	HK$157.0b	HK$36.0b	-HK$1,059,730,017.75	52.3x	-148.2x	4.4x
Tue, 31 Dec 2024	HK$159.8b	HK$35.6b	-HK$1,057,215,218.15	59.3x	-151.1x	4.5x
Thu, 28 Nov 2024	HK$136.6b	HK$35.9b	-HK$1,057,881,329.23	49.9x	-129.1x	3.8x
Sat, 26 Oct 2024	HK$163.9b	HK$35.7b	-HK$660,329,393.64	31.6x	-248.3x	4.6x
Mon, 23 Sep 2024	HK$153.6b	HK$36.1b	-HK$655,358,792.46	26.4x	-234.4x	4.3x
Wed, 21 Aug 2024	HK$101.8b	HK$35.1b	HK$2.5b	16.3x	40.8x	2.9x
Fri, 19 Jul 2024	HK$96.2b	HK$33.4b	HK$3.1b	18.5x	31.2x	2.9x
Sun, 16 Jun 2024	HK$91.5b	HK$33.5b	HK$3.1b	24x	29.7x	2.7x
Tue, 14 May 2024	HK$109.0b	HK$33.5b	HK$3.1b	29.9x	35.2x	3.2x
Thu, 11 Apr 2024	HK$115.6b	HK$33.6b	HK$3.1b	33.9x	37.3x	3.4x
Sat, 09 Mar 2024	HK$133.1b	HK$32.3b	HK$3.0b	59.7x	44.7x	4.1x
Mon, 05 Feb 2024	HK$124.4b	HK$32.3b	HK$3.0b	52.6x	41.8x	3.9x
Wed, 03 Jan 2024	HK$206.3b	HK$32.4b	HK$3.0b	88.9x	68.7x	6.4x
Fri, 01 Dec 2023	HK$272.8b	HK$32.4b	HK$3.0b	86x	90.8x	8.4x
Sun, 29 Oct 2023	HK$255.3b	HK$30.1b	HK$2.7b	45.7x	95.9x	8.5x
Tue, 26 Sep 2023	HK$234.8b	HK$30.1b	HK$2.7b	41.8x	88.1x	7.8x
Thu, 24 Aug 2023	HK$221.5b	HK$28.9b	HK$3.0b	23.8x	73.1x	7.7x
Sat, 22 Jul 2023	HK$221.3b	HK$28.5b	HK$2.7b	23.4x	80.9x	7.8x
Mon, 19 Jun 2023	HK$251.8b	HK$28.7b	HK$2.8b	22.8x	90.9x	8.8x
Wed, 17 May 2023	HK$250.1b	HK$29.3b	HK$2.9b	22.3x	86.7x	8.5x
Fri, 14 Apr 2023	HK$279.5b	HK$29.6b	HK$3.0b	18.2x	93.3x	9.4x
Sun, 12 Mar 2023	HK$270.0b	HK$26.3b	HK$2.0b	23.6x	132x	10.3x

Price to Earnings Ratio

132x

Sun, 12 Mar 2023

Current Industry PE

Investors are optimistic on the Hong Kong Life Sciences industry, and appear confident in long term growth rates.

The industry is trading at a PE ratio of 56.1x which is higher than its 3-year average PE of 10.3x.

The 3-year average PS ratio of 6.2x is lower than the industry's current PS ratio of 7.8x.

Past Earnings Growth

The earnings for companies in the Life Sciences industry have grown 44% per year over the last three years.
Revenues for these companies have grown 18% per year.
This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.